Oct 19 (Reuters) - Sun Pharmaceutical Industries Ltd :
* Sun Pharma & ICGEB announce new exclusive collaboration to develop novel dengue vaccine for India & global markets
* Says current collaboration is focussed on developing a novel, safe & effective vaccine for the prevention of dengue
* Sun pharma to explore global commercialisation opportunities for vaccine across India, emerging markets, western Europe, Japan, USA
* Sun Pharma to set-up dengue vaccine advisory group to provide technical,regulatory support to vaccine development program
* Co to be exclusively responsible for all regulatory filings for product globally including CDSCO-India, WHO, USFDA, EMA, MHRA, etc Source text: bit.ly/2e0noLf Further company coverage: (Bengaluru newsroom)
Our Standards: The Thomson Reuters Trust Principles.